SLC6A3 and Parkinson disease: In this study, we used DAT glycosylation as a breakthrough point to explore the intrinsic mechanism of GDNF to promote DAT membrane transport in DA neurons, which not only deepens our understanding of the potential of GDNF for Parkinson's disease, but also has implications in the field of clinical application.